Phase 1 Multiple Ascending Dose Studies Demonstrate Favorable Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator (P9-9.011)

Authors

Christopher Jensen
Irfan Qureshi (ORCID: https://orcid.org/0000-0002-0572-0993)
Heather Sevinsky
Randall Killingsworth
Vladimir Coric
Michael Bozik
Andrea Ivans
Steven I. Dworetzky
Eric Ashbrenner
Bharat Awsare
Jason T. Lerner

Institutions

Biohaven Pharmaceuticals (United States) (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000211227
Primary Topic: Electrostatic Discharge in Electronics
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Phase 1 Multiple Ascending Dose Studies Demonstrate Favorable Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator (P9-9.011)

Christopher Jensen, Irfan Qureshi, Heather Sevinsky, Randall Killingsworth et al.

Apr 7, 2025

Neurology

Electrostatic Discharge in Electronics

article

Phase 1 Multiple Ascending Dose Studies Demonstrate Favorable Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator (P9-9.011)

Christopher Jensen, Irfan Qureshi, Heather Sevinsky, Randall Killingsworth, Vladimir Coric, Michael Bozik, Andrea Ivans, Steven I. Dworetzky, Eric Ashbrenner, Bharat Awsare, Jason T. Lerner

April 7, 2025article en

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Biohaven Pharmaceuticals (United States) (US)

Good health and well-being

Openalex Percentile: Top 95%

Electrostatic Discharge in Electronics

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase 1 Multiple Ascending Dose Studies Demonstrate Favorable Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator (P9-9.011) — Christopher Jensen, Irfan Qureshi, et al. · Neurology (2025) | TGRS Research Map | TGRS